Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory analysis study
Anant Ramaswamy1, Vikas Ostwal1, Nikhil Pande1, Atul Sharma2, Shekar Patil3, Ravi Thippeswamy4, Nikhil Ghadyalpatil5, Rakesh Roy6, Harish Peshwe7, Bhavesh Poladia8, Deepan Rajamanickam8, Bharat Rangarajan9, PR Neelesh Reddy10, Vimal Pandita11, Ashis Mukherjee12, Aniket Thoke13, Abhijit Sarkar14, CT Satish3, H Shashidara3, SD Banavali1
1 Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India 2 Department of Medical Oncology, Dr. B. R. A IRCH, AIIMS, New Delhi, India 3 Department of Medical Oncology, HCG, Bengaluru, Karnataka, India 4 Department of Medical Oncology, Sri Shankara Cancer Hospital, Bengaluru, Karnataka, India 5 Department of Medical Oncology, Yashoda Cancer Institute, Hyderabad, Telangana, India 6 Saroj Gupta Cancer Centre and Research Institute, Kolkata, West Bengal, India 7 Department of Gastroenterology and Hepatology, Healthway Hospitals, Panjim, Goa, India 8 Thangam Cancer Center, Namakkal, Tamil Nadu, India 9 Kovai Medical Center and Hospital, Coimbatore, Tamil Nadu, India 10 Department of Medical Oncology, Columbia Asia Hospital, Bengaluru, Karnataka, India 11 Department of Medical Oncology, Max Superspeciality Hospital, Dehradun, Uttarakhand, India 12 Department of Oncology, Netaji Subhash Chandra Bose Cancer Research Institute, Kolkata, West Bengal, India 13 Department of Oncology, Sanjeevani CBCC USA Cancer Hospital, Raipur, Chhattisgarh, India 14 Saroj Gupta Cancer Center and Research Institute, Kolkata, West Bengal, India
Correspondence Address:
Vikas Ostwal Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/sajc.sajc_173_18
|